Shanghai Huayi Group (600623) Fair Value & Analysis
Basic Materials · CN · Market cap 18.4B CNY
Analysis
Shanghai Huayi Group (600623) currently trades at ¥8.73, while our model-based Fair Value estimate is ¥12.56 — implying the stock looks roughly 43.9% undervalued today. We read business quality at 79/100 (high quality), in the Basic Materials sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: medium) — always confirm before acting.
About the company
Shanghai Huayi Group Corporation Limited operates as a chemical company in China. The company offers methanol, acetic acid, carbon monoxide, synthesis gas and sulfuric acid, air separation products, etc. for chemical, pharmaceutical, textile printing and dyeing, and rubber industries and other industries. It also provides support services for water, electricity, steam, and other public works, as well as special railway lines and dangerous chemical goods terminals; and dangerous chemical goods transport vehicles and other logistics facilities. In addition, the company offers all-steel radial truck, all steel radial light truck, and passenger tires; and acrylic, ice crystal acrylic acid, butyl acrylate, ethyl acrylate, isooctyl acrylate, hydroxyethyl acrylate, and other products under the Yaxing brand for used in coatings, chemical fiber, textile, light, and other industries. The company was formerly known as Double Coin Holdings Ltd. Shanghai Huayi Group Corporation Limited was found…
Open the full interactive analysis →
Similar stocks
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.